Remove 2018 Remove Medication Remove Tests
article thumbnail

When Trials Find Implausible Results—The SCOT-HEART trial

Sensible Medicine

An imaging test. One group of patients with chest pain received standard stress testing; the other received standard stress testing plus a coronary CT scan (CCTA). The Edinburgh-based team presented their 5-year results in 2018, and their 10-year results last week. Not a drug. Not an intervention. Both were positive.

Tests 301
article thumbnail

Do I Really Need That? Patients Wary of Conflicts of Interest in Healthcare

Scrubs

However, much of that spending may not be medically necessary. Providers are typically paid for each test and procedure they perform, which can lead to a conflict of interest, especially when patients have to foot the bill. Find out why medically unnecessary care is on the rise and what patients can do to protect themselves.

Tests 230
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Optum: Testing Time for an Invisible Empire

The Healthcare Blog

Then someone discovered that the largest living thing in the world was actually the 106 acre, 47 thousand tree Pando aspen grove in central Utah, which genetic testing revealed to be a single organism. However, Optum Health’s profit margin declined from more than 10% in 2018 to about 6.6% Optum Health is a $95.3 It generates nearly $6.6

Tests 130
article thumbnail

The Infomercial Comes to The Wall Street Journal

Sensible Medicine

Have I been neglecting the medical literature? For calcium deposits in breast arteries to be important, we would need to know that some action based on this finding, whether it be further diagnostic testing, lifestyle modification, or medical therapy, actually benefits a woman. Why didn’t I know this?

Tests 186
article thumbnail

Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018

Health Populi

The study, Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer, was published in The New England Journal of Medicine on June 3, 2018, coinciding with the researchers’ ASCO presentation of the results. ” A genetic test that costs $3,000 helps to identify women who could benefit from avoiding chemo.

article thumbnail

Neuralink Brain Implant Gets FDA Approval for First Human Clinical Trial

Scrubs

The latest approval frees the company from having to test its products on animals. The news comes as Neuralink is being investigated for possibly rushing the testing process. lawmakers asked regulators to look into the Neuralink panel that oversees the startup’s animal testing. As recently as last month, several U.S.

Tests 186
article thumbnail

Peter Attia, Outlive, Cardiology 3.0 and primordial prevention of heart attacks

Sensible Medicine

Designed to help fund good nutritional research with the ultimate goal of reducing obesity and testing the hypothesis that “all calories are equal,” NUSI, unfortunately has floundered and is dead. He now knows these numbers indicate high levels of apoB "but no one bothered to test my apoB number."

Tests 279